CSIMarket
 
Dr Reddy s Laboratories Limited  (RDY)
Other Ticker:  
 
 
Price: $75.4900 $0.25 0.332%
Day's High: $75.785 Week Perf: -1.09 %
Day's Low: $ 75.34 30 Day Perf: 0.64 %
Volume (M): 245 52 Wk High: $ 77.72
Volume (M$): $ 18,488 52 Wk Avg: $65.79
Open: $75.65 52 Wk Low: $53.12



 Market Capitalization (Millions $) 12,534
 Shares Outstanding (Millions) 166
 Employees 22,000
 Revenues (TTM) (Millions $) 2,992
 Net Income (TTM) (Millions $) 548
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 138

Dr Reddy S Laboratories Limited
Dr. Reddy's Laboratories is one of the leading global pharmaceutical companies, headquartered in Hyderabad, India. The company was founded in 1984 and has since grown to become a global player in the pharmaceutical industry, with a presence in over 100 countries.

The company's primary focus is on developing and manufacturing generic drugs, biosimilars, and innovative pharmaceutical products. Dr. Reddy's product portfolio includes a wide range of therapeutic areas such as cardiovascular, oncology, neurology, dermatology, and gastroenterology.

One of the key strengths of Dr. Reddy's is its R&D capabilities. The company has a dedicated team of scientists and researchers who work on developing new drugs, improving formulations, and enhancing the efficiency of existing products. Dr. Reddy's has invested significantly in building state-of-the-art R&D facilities and collaborations with leading academic institutions and research organizations.

In addition to generic and biosimilar drugs, Dr. Reddy's also has a strong presence in the consumer health business through its subsidiary, Dr. Reddy's Laboratories, Inc. The company has a portfolio of OTC products such as pain relievers, cough and cold remedies, and digestive health supplements.

Dr. Reddy's has a global presence with manufacturing facilities in multiple countries, including India, the US, Mexico, and Russia. The company's sales and marketing activities are also spread across different geographies, with a significant focus on the US and Europe.

In recent years, Dr. Reddy's has made significant strides in creating a more sustainable business model, with a focus on reducing its carbon footprint, conserving energy, and developing eco-friendly products. The company is also committed to giving back to society, with initiatives such as providing free healthcare to underprivileged communities and supporting education programs.

Overall, Dr. Reddy's Laboratories is a well-established, innovative, and socially responsible organization that is poised for continued growth in the global pharmaceutical industry.


   Company Address: 8-2-337 Hyderabad 500
   Company Phone Number: 49002931   Stock Exchange / Ticker: NYSE RDY
   RDY is expected to report next financial results on June 12, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Dr Reddy S Laboratories Limited

Dr Reddy's Laboratories Limited Skyrockets with a Staggering 5.874% Revenue Uplift- All in the Last Fiscal Period!

Dr Reddy's Laboratories Limited, a major player in the pharmaceutical preparations industry, has reported impressive financial results for their most recent fiscal period. The company's income per share surged by 76.47% to reach $3.30 per share, up from $1.87 in the previous year, and a significant improvement from the previous reporting period where earnings per share were at $0.00. This result indicates a strong profitability increase for the company, driven by the successful execution of their business strategy.
Additionally, the company's revenue grew by 5.87% to $2.99 billion from $2.83 billion in the previous fiscal period, reflecting the sales from Dr Reddy's latest drugs and therapies, as well as some strategic partnerships established by the company. The net earnings for the period stood at $548 million, increasing by 76.21% from the previous year's net earnings of $311 million.






 

Dr Reddy S Laboratories Limited's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com